tirzepatide cvot trial cardiovascular outcomes results august 2025 Matches Dulaglutide in Large CV Trial: SURPASS-CVOT Tirzepatide Improves HFpEF Symptoms and – An Observational Study of Cardiovascular – UC Irvine researchers project cardiac
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13



























